Frequency of Ki-67 (MIB-1) and P53 expressions among patients with prostate cancer

Indian J Pathol Microbiol. 2011 Oct-Dec;54(4):688-91. doi: 10.4103/0377-4929.91492.

Abstract

Context: Prostate cancer is the most common malignant tumor in men. Tumor grade is one of the most important prognostic factors of prostate cancer. P53 and Ki-67 expressions have also been considered to be prognostic factors.

Aims: This study was performed to investigate the frequency of these proteins expression and compare the obtained results with Gleason's grading.

Settings and design: In this cross-sectional study, 49 paraffin blocks of prostate cancers were assessed. Tumor grade was determined according to the Gleason's criteria.

Materials and methods: Ki-67 and P53 expressions were determined by immunohistochemical staining.

Statistical analysis: The obtained results were analyzed and evaluated using Spearman's statistical test (SPSS version 15).

Results: Three out of 49 (6.1%) cases were well differentiated, 21 (43%) moderately differentiated and 25 (51%) were poorly differentiated. P53 was negative in all well-differentiated cases. Ki-67 was negative in 14 cases (28%) including all well-differentiated tumors. Among moderately and poorly differentiated tumors Ki-67 was negative in eight (38%) and three (12%) of cases, respectively. A statistically significant relation was observed between the increased Ki-67 labeling index (LI) and increased Gleason's grade. Conversely, no statistically significant relation was found between P53 expression and increased Gleason's grade.

Conclusions: According to the findings of this study, it seems that Ki-67 can be used as a prognostic factor for prostate cancer. On the other hand, the probable relation between P-53 and prostate cancer prognosis requires further studies.

Publication types

  • Evaluation Study

MeSH terms

  • Aged
  • Aged, 80 and over
  • Biomarkers, Tumor / analysis*
  • Cross-Sectional Studies
  • Humans
  • Immunohistochemistry / methods*
  • Ki-67 Antigen / analysis*
  • Male
  • Middle Aged
  • Prognosis
  • Prostatic Neoplasms / diagnosis*
  • Prostatic Neoplasms / pathology*
  • Severity of Illness Index
  • Tumor Suppressor Protein p53 / analysis*

Substances

  • Biomarkers, Tumor
  • Ki-67 Antigen
  • Tumor Suppressor Protein p53